Literature DB >> 2881442

Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.

M Da Prada, R Kettler, H H Keller, E P Bonetti, R Imhof.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2881442

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  2 in total

1.  Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327.

Authors:  C J Bench; G W Price; A A Lammertsma; J C Cremer; S K Luthra; D Turton; R J Dolan; R Kettler; J Dingemanse; M Da Prada
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491.

Authors:  H H Keller; R Kettler; G Keller; M Da Prada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.